Andrew Do

1.1k total citations
21 papers, 443 citations indexed

About

Andrew Do is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Andrew Do has authored 21 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Andrew Do's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (8 papers) and Cancer therapeutics and mechanisms (4 papers). Andrew Do is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (8 papers) and Cancer therapeutics and mechanisms (4 papers). Andrew Do collaborates with scholars based in United States, Germany and Poland. Andrew Do's co-authors include W. Marston Linehan, Justin F. Gainor, Ibiayi Dagogo‐Jack, Lecia V. Sequist, Jochen K. Lennerz, Jennifer Peterson, Aaron N. Hata, Viola W. Zhu, Adam Gesing and Mari Mino–Kenudson and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and Annals of Oncology.

In The Last Decade

Andrew Do

20 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Do United States	11	233	179	143	77	60	21	443
Nello Grassi Italy	8	107 0.5×	252 1.4×	91 0.6×	75 1.0×	26 0.4×	22	472
Diping Wang United States	8	89 0.4×	105 0.6×	445 3.1×	86 1.1×	13 0.2×	13	619
Akiharu Kimura Japan	12	286 1.2×	225 1.3×	226 1.6×	62 0.8×	11 0.2×	51	625
Hamza M. Al-tamari Germany	6	269 1.2×	137 0.8×	250 1.7×	91 1.2×	5 0.1×	6	556
Maria Gebre‐Medhin Sweden	9	122 0.5×	113 0.6×	80 0.6×	51 0.7×	96 1.6×	18	371
Augusto Nogueira Portugal	14	123 0.5×	133 0.7×	243 1.7×	155 2.0×	8 0.1×	29	417
Tianbo Jin China	15	55 0.2×	77 0.4×	301 2.1×	137 1.8×	15 0.3×	48	522
Takahito Sugase Japan	10	135 0.6×	142 0.8×	157 1.1×	49 0.6×	53 0.9×	58	473
Facai Zhang China	15	177 0.8×	77 0.4×	214 1.5×	193 2.5×	7 0.1×	27	444

Countries citing papers authored by Andrew Do

Since Specialization

Citations

This map shows the geographic impact of Andrew Do's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Do with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Do more than expected).

Fields of papers citing papers by Andrew Do

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Do. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Do. The network helps show where Andrew Do may publish in the future.

Co-authorship network of co-authors of Andrew Do

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Do. A scholar is included among the top collaborators of Andrew Do based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Do. Andrew Do is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Waliany, Sarah, B.Y. Yeap, Jennifer Peterson, et al.. (2025). Adverse events associated with sequential immune checkpoint inhibitor and alectinib in patients with ALK-rearranged advanced non-small-cell lung cancer. ESMO Open. 10(10). 105842–105842. 1 indexed citations

Waliany, Sarah, Yin P. Hung, Marzia Capelletti, et al.. (2025). Lung Carcinoid Tumors With Potentially Actionable Genomic Alterations and Responses to Targeted Therapies. Clinical Lung Cancer. 26(5). 354–363.e5. 2 indexed citations

Waliany, Sarah, et al.. (2025). Shifting landscape of resistance to next-generation ALK inhibitors with evolving treatment paradigm in ALK+ lung cancer.. Journal of Clinical Oncology. 43(16_suppl). 8607–8607. 1 indexed citations

Waliany, Sarah, Andrew Do, Aimin Liu, et al.. (2024). P1.12B.02 Mechanisms of Resistance to First-Line vs Later-Line Alectinib in ALK Fusion-Positive Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 19(10). S199–S200. 2 indexed citations

Yeap, Beow Y., Jennifer Peterson, Andrew Do, et al.. (2024). Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib. JTO Clinical and Research Reports. 5(3). 100645–100645. 3 indexed citations

Waliany, Sarah, Yin P. Hung, Andrew Do, et al.. (2024). PP01.69 Atypical Lung Carcinoids with EML4-ALK Fusion and Responses to ALK Inhibitors. Journal of Thoracic Oncology. 19(7). e32–e33.

Dagogo‐Jack, Ibiayi, Lesli A. Kiedrowski, Rebecca S. Heist, et al.. (2023). Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis. JTO Clinical and Research Reports. 4(8). 100534–100534. 9 indexed citations

Schneider, Jaime L., Mari Mino–Kenudson, Subba R. Digumarthy, et al.. (2023). Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution. npj Precision Oncology. 7(1). 116–116. 6 indexed citations

Dagogo‐Jack, Ibiayi, Antonello Abbattista, Stan Krulewicz, et al.. (2022). Factors Associated With Developing Neurocognitive Adverse Events in Patients Receiving Lorlatinib After Progression on Other Targeted Therapies. Journal of Thoracic Oncology. 18(1). 67–78. 21 indexed citations

10.

Dagogo‐Jack, Ibiayi, Philicia Moonsamy, Justin F. Gainor, et al.. (2021). A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor. Journal of Thoracic Oncology. 16(5). 850–859. 40 indexed citations

11.

Choudhury, Noura J., Jaime L. Schneider, Tejas Patil, et al.. (2021). Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers. JTO Clinical and Research Reports. 2(7). 100187–100187. 26 indexed citations

12.

Linehan, W. Marston, Stephen V. Liu, Caroline E. McCoach, et al.. (2020). Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer. Annals of Oncology. 31(12). 1725–1733. 161 indexed citations

13.

Digumarthy, Subba R., Dexter P. Mendoza, W. Marston Linehan, et al.. (2020). Imaging Features and Patterns of Metastasis in Non-Small Cell Lung Cancer with RET Rearrangements. Cancers. 12(3). 693–693. 19 indexed citations

14.

Bennett, Stephanie, et al.. (2019). 18 Improving the Safety of Insulin Treatment for Hyperkalemia. Annals of Emergency Medicine. 74(4). S8–S9. 1 indexed citations

15.

Ho‐Pham, Lan T., et al.. (2018). Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study. Osteoporosis International. 29(9). 2059–2067. 29 indexed citations

16.

Bennis, Mohamed, Augusto Schneider, Berta Victoria, et al.. (2017). The role of transplanted visceral fat from the long-lived growth hormone receptor knockout mice on insulin signaling. GeroScience. 39(1). 51–59. 32 indexed citations

17.

Gesing, Adam, Andrew Do, Augusto Schneider, et al.. (2016). A Long-lived Mouse Lacking Both Growth Hormone and Growth Hormone Receptor: A New Animal Model for Aging Studies. The Journals of Gerontology Series A. 72(8). glw193–glw193. 27 indexed citations

18.

Toomer, Ondulla T., Martine Ferguson, Marion Pereira, et al.. (2014). Maternal and postnatal dietary probiotic supplementation enhances splenic regulatory T helper cell population and reduces peanut allergen-induced hypersensitivity responses in mice. Immunobiology. 219(9). 661–670. 6 indexed citations

19.

Zhi, Xu, Andrew Do, Adam Gesing, et al.. (2014). The effect of calorie restriction on insulin signaling in skeletal muscle and adipose tissue of Ames dwarf mice. Aging. 6(10). 900–912. 19 indexed citations

20.

Toomer, Ondulla T., Andrew Do, Marion Pereira, & Kristina M. Williams. (2013). Effect of Simulated Gastric and Intestinal Digestion on Temporal Stability and Immunoreactivity of Peanut, Almond, and Pine Nut Protein Allergens. Journal of Agricultural and Food Chemistry. 61(24). 5903–5913. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact